Skip to main content
Publications
Osborne R, Nelson L , Fehnel S , Williams N, Bender RH , Ziemiecki R , Gymnopoulou E, De Paepe E, Norcross L , Heijnen E, Ispas G, Cheret A, Comeaux C, Callendret B, Vandendijck Y, Chan E, Scott J. Measurement of symptoms in respiratory syncytial virus–infected adults: meaningful within-patient change thresholds for the respiratory infection intensity and impact questionnaire (RiiQ) . Poster presented at the 8th ESWI Influenza Conference Scientific and SPI Virtual Programme; December 4, 2021.
Osborne RH, Nelson L , Elsworth GR, Fehnel S , Williams N, Bender RH , Ziemiecki R , Gymnopoulou E, De Paepe E, Norcross L , Heijnen E, Ispas G, Cheret A, Comeaux C, Chan E, Scott JA. Psychometric evaluation of the Respiratory Infection Intensity and Impact Questionnaire Version 2 (RiiQ™v2) symptom scores for respiratory syncytial virus . Poster presented at the Virtual ISPOR 2021 Conference; May 2021.
Cohen JL, Sadick NS, Kirby MT, McLane MP, Lenderking WR, Bender RH , Chen J, Hurley D, Knoble NB, Liu G, Xiang Q, Davidson JA, Goldman MP. Development and validation clinician and patient reported photonumeric scales to assess buttocks cellulite severity . Dermatol Surg. 2020 Dec;46(12):1628-35. doi: 10.1097/DSS.0000000000002756
Matza LS, Brazier JE, Stewart KD, Pinto L, Bender RH , Kircik L, Jordan J, Kim KJ, Mutebi A, Viswanathan HN, Menter A. Developing a preference-based utility scoring algorithm for the Psoriasis Area Severity Index (PASI) . J Med Econ. 2019 Sep;22(9):936-44. doi: 10.1080/13696998.2019.1627362
Marshall RD, Collins A, Escolar ML, Jinnah HA, Klopstock T, Kruer MC, Videnovic A, Robichaux-Viehoever A, Burns C, Swett LL, Revicki DA, Bender RH , Lenderking WR. Diagnostic and clinical experience of patients with pantothenate kinase-associated neurodegeneration . Orphanet J Rare Dis. 2019 Jul 12;174(2019). doi: 10.1186/s13023-019-1142-1
Marshall RD, Collins A, Escolar ML, Jinnah HA, Klopstock T, Kruer MC, Videnovic A, Robichaux-Viehoever A, Swett L, Revicki DA, Bender RH , Lenderking WR. A scale to assess activities of daily living in pantothenate kinase‐associated neurodegeneration . Mov Disord Clin Pract. 2019 Feb;6(2):139-49. doi: 10.1002/mdc3.12716
Jinnah H, Lenderking W, Collins A, Escolar M, Klopstock T, Kruer M, Videnovic A, Robichaux-Viehoever A, Swett L, Revicki D, Bender R , Marshall R. Patient and caregiver experience with pantothenate kinase-associated neurodegeneration . Poster presented at the 2018 International Congress of Parkinson’s Disease and Movement Disorders International Meeting; October 6, 2018. Hong Kong, China. [abstract] Mov Disord. 2018 Dec; 33(suppl 2):484.
Weiss C, Bouerat Duvold L, Lenderking WR, Cooper O, Shalhoub H, Kleinman L, Bender R , Hartry A, Green M, Meehan SR, Tandon R. The impact of second-generation antipsychotic medication side-effects on functioning from a schizophrenia patient perspective: a cross-sectional, observational, patient centered, web survey study . Poster presented at the 2018 Annual Meeting of the American Society of Clinical Psychopharmacology (ASCP); May 2018. Miami Beach, FL.
Kawata AK, Hsieh R, Bender R , Shaffer S, Revicki DA, Bayliss M, Buse DC, Desai P, Sapra S, Ortmeier B, Hareendran A. Psychometric evaluation of a novel instrument assessing the impact of migraine on physical functioning: the Migraine Physical Function Impact Diary . Headache. 2017 Oct;57(9):1385-98. doi: 10.1111/head.13162
Marshall R, Collins A, Escolar M, Jinnah HA, Klopstock T, Kruer M, Videnovic A, Robichaux-Viehoeve A, Swett L, Revicki D, Bender R , Lenderking W. Development of a Clinical Outcomes Assessment (COA) in Pantothenate-Kinase Associated Neurodegeneration (PKAN): item generation and clinimetric properties . Presented at the 2017 International Congress of Parkinson’s Disease and Movement Disorders; June 8, 2017. Vancouver, Canada. [abstract] Mov Disord. 2017 Jun; 32(suppl 2).
Kawata AK, Hsieh R, Hareendran A, Bender RH , Shaffer S, Sapra S, Desai P, Widnell K, Bayliss M, Buse DC, Revicki DA. Psychometric properties of the Migraine Physical Function Impact Diary (MPFID) . Poster presented at the 2016 23rd Annual Conference of the International Society for Quality of Life Research (ISOQOL); October 2016. Copenhagen, Denmark. [abstract] Qual Life Res. 2016 Oct; 25(1):28.
Mills A, Garner W, Pozniak A, Berenguer J, Speck RM, Bender R , Nguyen T. Patient-reported symptoms over 48 weeks in a randomized, open-label, phase IIIb non-inferiority trial of adults with HIV switching to co-formulated elvitegravir, cobicistat, emtricitabine, and tenofovir DF versus continuation of non-nucleoside reverse transcriptase inhibitor with emtricitabine and tenofovir DF . Patient. 2015 Aug;8(4):359-71. doi: 10.1007/s40271-015-0129-9
Early DM, Maxwell KL, Burchinal M, Alva S, Bender RH , Bryant D, Cai K, Clifford RM, Ebanks C, Griffin JA, Henry GT, Howes C, Iriondo-Perez J, Jeon HJ, Mashburn AJ, Peisner-Feinberg E, Pianta RC, Vandergrift N, Zill N. Teacher's education, classroom quality, and young children's academic skills: results from seven studies of preschool programs . Child Dev. 2007 Mar;78(2):558-80.